| VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance MA ElTanbouly, Y Zhao, E Nowak, J Li, E Schaafsma, I Le Mercier, ... Science 367 (6475), eaay0524, 2020 | 181 | 2020 |
| VISTA: Coming of age as a multi-lineage immune checkpoint MA ElTanbouly, E Schaafsma, RJ Noelle, JL Lines Clinical & Experimental Immunology 200 (2), 120-130, 2020 | 88 | 2020 |
| Pan-cancer association of HLA gene expression with cancer prognosis and immunotherapy efficacy E Schaafsma, CM Fugle, X Wang, C Cheng British journal of cancer 125 (3), 422-432, 2021 | 76 | 2021 |
| Profibrotic activation of human macrophages in systemic sclerosis R Bhandari, MS Ball, V Martyanov, D Popovich, E Schaafsma, S Han, ... Arthritis & Rheumatology 72 (7), 1160-1169, 2020 | 60 | 2020 |
| Defining the signature of VISTA on myeloid cell chemokine responsiveness TWK Broughton, MA ElTanbouly, E Schaafsma, J Deng, A Sarde, ... Frontiers in immunology 10, 2641, 2019 | 42 | 2019 |
| Impact of Oncotype DX testing on ER+ breast cancer treatment and survival in the first decade of use E Schaafsma, B Zhang, M Schaafsma, CY Tong, L Zhang, C Cheng Breast Cancer Research 23, 1-11, 2021 | 41 | 2021 |
| Genomic characterization of six virus-associated cancers identifies changes in the tumor immune microenvironment and altered genetic programs FS Varn, E Schaafsma, Y Wang, C Cheng Cancer research 78 (22), 6413-6423, 2018 | 37 | 2018 |
| VISTA: a target to manage the innate cytokine storm MA ElTanbouly, Y Zhao, E Schaafsma, CM Burns, R Mabaera, C Cheng, ... Frontiers in Immunology 11, 595950, 2021 | 36 | 2021 |
| A leukocyte infiltration score defined by a gene signature predicts melanoma patient prognosis Y Zhao, E Schaafsma, IP Gorlov, E Hernando, NE Thomas, R Shen, ... Molecular Cancer Research 17 (1), 109-119, 2019 | 31 | 2019 |
| VISTA re-programs macrophage biology through the combined regulation of tolerance and anti-inflammatory pathways MA ElTanbouly, E Schaafsma, NC Smits, P Shah, C Cheng, C Burns, ... Frontiers in immunology 11, 580187, 2020 | 30 | 2020 |
| Gene signature‐based prediction of triple‐negative breast cancer patient response to Neoadjuvant chemotherapy Y Zhao, E Schaafsma, C Cheng Cancer Medicine 9 (17), 6281-6295, 2020 | 23 | 2020 |
| B cell infiltration is highly associated with prognosis and an immune-infiltrated tumor microenvironment in neuroblastoma E Schaafsma, C Jiang, C Cheng Journal of cancer metastasis and treatment 7 (34), 2021 | 17 | 2021 |
| Anticancer activities of resveratrol in colorectal cancer E Schaafsma, T Hsieh, BB Doonan, JT Pinto, JM Wu | 17 | 2016 |
| VISTA targeting of T-cell quiescence and myeloid suppression overcomes adaptive resistance E Schaafsma, W Croteau, M ElTanbouly, EC Nowak, NC Smits, J Deng, ... Cancer immunology research 11 (1), 38-55, 2023 | 15 | 2023 |
| An EGFR signature predicts cell line and patient sensitivity to multiple tyrosine kinase inhibitors C Cheng, Y Zhao, E Schaafsma, YL Weng, C Amos International journal of cancer 147 (9), 2621-2633, 2020 | 15 | 2020 |
| Predicting clinical outcomes of cancer patients with a p53 deficiency gene signature E Schaafsma, EM Takacs, S Kaur, C Cheng, M Kurokawa Scientific reports 12 (1), 1317, 2022 | 13 | 2022 |
| Application of open-access databases to determine functional connectivity between resveratrol-binding protein QR2 and colorectal carcinoma BB Doonan, E Schaafsma, JT Pinto, JM Wu, T Hsieh In Vitro Cellular & Developmental Biology-Animal 53, 575-578, 2017 | 13 | 2017 |
| A TMPRSS2‐ERG gene signature predicts prognosis of patients with prostate adenocarcinoma E Zhou, B Zhang, K Zhu, E Schaafsma, RD Kumar, C Cheng Clinical and Translational Medicine 10 (8), 2020 | 10 | 2020 |
| Computational STAT3 activity inference reveals its roles in the pancreatic tumor microenvironment E Schaafsma, Y Yuan, Y Zhao, C Cheng Scientific Reports 9 (1), 18257, 2019 | 8 | 2019 |
| MYC activity inference captures diverse mechanisms of aberrant MYC pathway activation in human cancers E Schaafsma, Y Zhao, L Zhang, Y Li, C Cheng Molecular Cancer Research 19 (3), 414-428, 2021 | 7 | 2021 |
